A CA repeat polymorphism of the IFN-gamma gene is associated with susceptibility to type 1 diabetes

J Interferon Cytokine Res. 2000 Feb;20(2):187-90. doi: 10.1089/107999000312595.


Recent studies have shown that loci outside the HLA region are involved in determining susceptibility to type 1 diabetes. Polymorphisms in the coding and noncoding regions of the genes encoding cytokines may be involved in modulating the immune response to self and nonself antigens. There is increasing evidence that an imbalance and disruption of the Thl and Th2 T cell subsets play a key role in the development of experimental and clinical type 1 diabetes. The aim of this study was to investigate the frequency of a CA dinucleotide repeat polymorphism in the interferon-gamma (IFN-gamma) gene (IFNG) and a C(-590)T polymorphism of the interleukin-4 (IL-4) gene in 236 Caucasoid patients with type 1 diabetes. There was a highly significant increase in the 3/3 IFNG genotype in the patients compared with normal healthy controls (34.3% vs. 13.5%, p<0.0001) as well as a significant increase in allele 3 of the IFNG locus in the patients compared with controls (51.9% vs. 31.7%, p<0.00001). In contrast, no significant differences were found in the frequency of the C(-590)T IL-4 polymorphism between patients and controls. These results suggest that polymorphisms of the IFNG gene may modify the function of this proinflammatory mediator and the response to pancreatic islet beta cells.

MeSH terms

  • Adolescent
  • Adult
  • Alleles
  • Base Sequence
  • Case-Control Studies
  • Child
  • DNA Primers / genetics
  • Diabetes Mellitus, Type 1 / genetics*
  • Diabetes Mellitus, Type 1 / immunology*
  • Dinucleotide Repeats*
  • Female
  • Gene Frequency
  • Humans
  • Infant, Newborn
  • Interferon-gamma / genetics*
  • Interleukin-4 / genetics
  • Islets of Langerhans / immunology
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Pregnancy
  • Self Tolerance / genetics


  • DNA Primers
  • Interleukin-4
  • Interferon-gamma